About the ICTR
The Johns Hopkins Institute for Clinical and Translational Research (ICTR), established in 2007, is one of more than 60 medical research institutions working together as a national consortium to improve the way biomedical research is conducted across the country.
The ICTR addresses obstacles in translating basic science discoveries into research in humans, translating clinical discoveries into the community and communicating experience from clinical practice back to researchers. The ICTR houses three Translational Research Communities for investigators across multiple disciplines that focus on drugs, biologics, vaccines and devices; biomarkers and diagnostic tests; and behavioral, social and systems interventions. These communities of researchers help prioritize clinical problems in need of new treatments, apply new technologies and methodologies, support junior investigators, work with translational partners outside of Johns Hopkins, fund pilot projects, provide regulatory assistance and promote efficient research. Another ICTR program, The Research Studio, provides both a place and a process for investigators and their teams to obtain multidisciplinary guidance to solve clinical and translational research problems.
Through a robust portfolio of training, education and career development programs, the ICTR also provides rigorous, comprehensive training to medical students, graduate students, fellows, junior faculty, practicing physicians and the wider research team, thus promoting the most effective, efficient, collaborative translational research enterprise.
Finally, using the Accelerating Translational Incubator Pilot grants, the ICTR encourages new translational research teams to take the risks necessary to go beyond their usual expertise and to find new collaborators, seek out new partners inside and outside the academic center, and learn new skills necessary to create the interventions the public is expecting.